Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Cross-Over Pilot Study of the Effectiveness of the Vector NIV Device in Hypercapnic COPD Patients With Expiratory Flow Limitation

NCT04263532 is registered in ClinicalTrials.gov with Philips Clinical & Medical Affairs Global as lead sponsor.

NCT NCT04263532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04263532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Cross-Over Pilot Study of the Effectiveness of the Vector NIV Device in Hypercapnic COPD Patients With Expiratory Flow Limitation
Lead sponsor
Philips Clinical & Medical Affairs Global
Phase
Not reported
Overall status
Terminated
Start date
January 21, 2020
Completion date
November 17, 2023
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease